Jefferies analyst Shan Hama maintained a Buy rating on Nanobiotix on May 22 and set a price target of €60.00. The company’s shares closed last Friday at €36.46.Meet Samuel – Your Personal Investing ProphetStart a conversation with TipRanks’ trusted, data-backed investment intelligence
Ask Samuel about stocks, your portfolio, or the market and get instant, personalized insights in seconds
According to TipRanks, Hama is ranked #8473 out of 12214 analysts.
The word on The Street in general, suggests a Strong Buy analyst consensus rating for Nanobiotix with a €55.00 average price target, representing a 50.85% upside. In a report released on May 22, Stifel Nicolaus also reiterated a Buy rating on the stock with a €45.00 price target.
Based on Nanobiotix’s latest earnings release for the quarter ending December 31, the company reported a quarterly revenue of €3.01 million and a GAAP net loss of €18.58 million. In comparison, last year the company had a GAAP net loss of €46.26 million
